| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5898860 | Diabetes Research and Clinical Practice | 2016 | 4 Pages |
Abstract
â¢Irisin levels were significantly elevated after CSII treatment in T2DM patients.â¢Elevated irisin was accompanied by improved glycemic control and lipid profiles.â¢Elevated irisin may represent benefits of ameliorative metabolism following CSII.
Irisin, identified as a novel myokine, plays an important role in improving metabolic disorders, including type 2 diabetes mellitus (T2DM). In this interventional study, we investigated the alteration of serum irisin levels in T2DM subjects after transient continuous subcutaneous insulin infusion (CSII) treatment.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Liang Li, Sharvan Rampersad, Xingchun Wang, Xiaoyun Cheng, Shen Qu,